{
    "nct_id": "NCT06370884",
    "official_title": "An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of Intestinal Microbiota Transplantation In Patients Undergoing Colon Resection",
    "inclusion_criteria": "* Able/willing to provide informed consent\n* Between 18-75 years of age\n* Undergoing surgery for a history of diverticulitis or sigmoid colon cancer.\n* Able to provide fecal samples\n* Stated willingness to comply with all study procedures and availability for the duration of trial to follow-up by telephone, in-person, email, and/or video visits or correspondence\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* Any history of inflammatory bowel disease\n* Pregnancy or breastfeeding. A pregnancy test will be obtained from females of child- bearing potential on the proposed day of IMT (prior to the receipt of IMT). Patients with a positive pregnancy test will be excluded. A negative result will be required for subjects who are females of child-bearing potential to receive IMT treatment.\n* Life expectancy of < 6 months\n* Presence of ileostomy or colostomy\n* Known history of inflammatory bowel disease (Crohn's, Ulcerative Colitis)\n* Patients on immunosuppressants (calcineurin inhibitors, prednisone â‰¥ 20 mg/day, methotrexate, azathioprine, immunosuppressive biologics, JAK inhibitors)\n* Patients with neutropenia (an absolute neutrophil count < 0.5 x 109 cells/L) obtained on a complete blood count with differential at screening.\n* History of solid organ or bone marrow transplant.\n* Anticipated recurrent antibiotic use (e.g., patients with frequent urinary tract infections or sinusitis).\n* History of severe anaphylactic food allergy.\n* History of celiac disease.\n* Patients receiving cancer chemotherapy, immunotherapy, or radiation.",
    "miscellaneous_criteria": ""
}